Offer - Urjas Oil for just ₹ 1 X
Dirifa 550 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
13 - 18 years (Adolescent) |
|
Geriatric |
|
Is the use of Dirifa 550 Tablet safe for pregnant women?
Dirifa has many dangerous side effects in pregnant women. If you are pregnant, do not consume Dirifa without medical advice.
Is the use of Dirifa 550 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Dirifa. It should only be taken after medical advice.
What is the effect of Dirifa 550 Tablet on the Kidneys?
There are no side effects of Dirifa on the kidneys.
What is the effect of Dirifa 550 Tablet on the Liver?
Dirifa is rarely harmful for the liver.
What is the effect of Dirifa 550 Tablet on the Heart?
Using Dirifa does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Dirifa 550 Tablet unless your doctor advises you to do so -
Is this Dirifa 550 Tablet habit forming or addictive?
Forming a habit of Dirifa 550 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Dirifa 550 Tablet does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Yes, but take Dirifa 550 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Dirifa 550 Tablet is not used to treat mental disorders.
Interaction between Food and Dirifa 550 Tablet
Taking Dirifa 550 Tablet with food does not harm your health.
Interaction between Alcohol and Dirifa 550 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Dirifa 550 Tablet.
Dirifa in combination with other antibiotics might be used to eradicate Helicobacter pylori (H. pylori) but it is generally not used and not approved for the treatment of the infection caused by H. pylori.
Dirifa works by inhibiting the bacterial protein synthesis which is essential for bacterial growth. The absence of these proteins results in stunned bacterial growth due to which bacteria is not able to survive. For hepatic encephalopathy Dirifa works by inhibiting the growth of enteric ammonia-producing bacteria which are present in our gut, this results in the indirect reduction of serum ammonia level. In irritable bowel syndrome with diarrhea, how Dirifa works are still unknown but it is presumed that it works by changing the bacterial flora in small intestine and reduction in gas.
No, Dirifa does not cause weight gain. It has not been reported by the patients who are taking this drug but Dirifa has been reported to cause weight loss in a few patients with travelers’ diarrhea. If you notice any unusual rapid weight changes after taking this drug then discuss with it your doctor and follow his/her instructions.
Yes, Dirifa might cause a headache. It is a rare side effect of this drug. However, the exact cause of a headache is still unknown. If you experience a severe headache after taking this drug, take a mild painkiller, apply balm and take rest even after this if the pain does not subside then discuss with your doctor without any further delay.
Rarely, Dirifa causes fatigue. It is an uncommon side effect of this drug. However, the exact cause of fatigue is unknown. If you experience tiredness after taking this drug, then try to take some rest even after that if you feel excessive tiredness then do discuss it with your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097